z-logo
open-access-imgOpen Access
Targeted prostate biopsy: 68Ga-PSMA PET/CT vs. mpMRI in the diagnosis of prostate cancer
Author(s) -
Pietro Pepe,
Ludovica Pepe,
Maria Tamburo,
Giulia Marletta,
Michele Pennisi,
Filippo Fraggetta
Publication year - 2022
Publication title -
archivio italiano di urologia e andrologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.429
H-Index - 23
eISSN - 2282-4197
pISSN - 1124-3562
DOI - 10.4081/aiua.2022.3.274
Subject(s) - medicine , prostate cancer , prostate , biopsy , radiology , cancer , prostate biopsy , urology , oncology
To evaluate the diagnostic accuracy of 68Ga-prostate-specic membrane antigen (PSMA) positron emission tomography/computed tomog-raphy (PET/CT) vs. multiparametric magnetic resonance imaging (mpMRI) targeted biopsy (TPBx) in the diagnosis of clinical-ly signicant prostate cancer (csPCa: Grade Group ≥ 2).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom